Eden Research plc Notice of AGM, investor conference & Accounts (0754B)
June 07 2021 - 10:28AM
UK Regulatory
TIDMEDEN
RNS Number : 0754B
Eden Research plc
07 June 2021
7 June 2021
Eden Research Plc
("Eden" or "Company")
Notice of AGM, virtual investor conference and 2020 Accounts
Eden Research plc (AIM: EDEN), the AIM-quoted company focused on
sustainable biopesticides and plastic-free formulation technology
for use in the global crop protection, animal health and consumer
products industries, announces that its Notice of the Annual
General Meeting ("AGM") has been issued to shareholders and is now
available on the Company's website: www.edenresearch.com
The AGM is to be held on Wednesday 30 June 2021 at 12.00pm at
67C Innovation Drive, Milton Park, Abingdon, Oxfordshire, OX14 4RQ
.
In accordance with current Government regulations in relation to
COVID-19, shareholders are encouraged to submit their Form of Proxy
in advance of the General Meeting and are strongly discouraged from
attending the General Meeting in person to safeguard the Company's
shareholders' and employees' health, to comply with current
Government guidelines, to minimise the unnecessary movement of
people and to make the AGM as safe and efficient as possible.
Should shareholders wish to ask any questions in relation to the
Resolutions, which they may otherwise have asked at the AGM, had
they been in attendance, they are encouraged to contact the Company
prior to the AGM by email at agm@edenresearch.com .
Virtual Investor Conference
Given the advised restrictions in place for the AGM due to
COVID-19, the Company shall be holding a virtual investor
conference at 1pm on 30 June 2021, where the executive team at Eden
shall make a presentation to shareholders and other interested
parties and shall answer questions that have been submitted to the
Board ahead of time. Should you have any questions for the Board,
please send them by email to agm@edenresearch.com by 5pm on Friday
25 June 2021.
Details of how to join the virtual investor conference shall
follow in due course.
2020 Accounts
In addition, and following discussions with the Company's
auditors and regulatory guidance in relation to the ongoing
COVID-19 pandemic, the Company has received an extension to the
timeline for filing its 2020 Accounts at Companies House.
Accordingly, the Company's consolidated accounts for the year ended
31 December 2020 (the "2020 Accounts") will not be presented at the
AGM.
The Company continues to work with its auditors to finalise its
2020 Accounts and, when available, the Company will issue an RNS
and dispatch the annual report and accounts to shareholders. At
that stage the Company intends to call a further general meeting to
receive the annual report and accounts.
For further information contact:
www.edenresearch.com
Eden Research plc
Sean Smith
Alex Abrey 01285 359 555
Cenkos Securities plc (Nominated advisor
and broker)
Giles Balleny / Camilla Hume/ Mark Connelly
(corporate finance)
Michael Johnson (sales) 020 7397 8900
Hawthorn Advisors (Financial PR)
Lorna Cobbett / Victoria Ainsworth eden@hawthornadvisors.com
Notes to Editors:
Eden Research is an AIM quoted company that develops and
supplies breakthrough biopesticide products and natural,
plastic-free microencapsulation technologies to the global crop
protection, animal health and consumer products industries.
Eden's Sustaine(R) encapsulation technology is used to harness
the biocidal efficacy of naturally occurring chemicals produced by
plants (terpenes) and can also be used with both natural and
synthetic compounds to enhance their performance and ease-of-use.
Sustaine microcapsules are naturally-derived, plastic-free,
biodegradable micro-spheres derived from yeast. It is one of the
only viable, proven and immediately registerable solutions to the
microplastics problem in formulations requiring encapsulation.
Eden has numerous patents and a pipeline of products at
differing stages of development targeting specific areas of the
global agrochemicals industry. Eden was admitted to trading on AIM
in May 2012.
For more information about Eden, please visit:
www.edenresearch.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOASSWFLWEFSEEM
(END) Dow Jones Newswires
June 07, 2021 10:28 ET (14:28 GMT)
Eden Research (AQSE:EDEN.GB)
Historical Stock Chart
From Jun 2024 to Jul 2024
Eden Research (AQSE:EDEN.GB)
Historical Stock Chart
From Jul 2023 to Jul 2024